CareRx Corporation (CHHHF)
USD 1.28
(0.0%)
USD 1.28
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 24.65 Million CAD | -2.77% |
| 2022 | -610 Thousand CAD | 39.14% |
| 2021 | 20.1 Million CAD | 136.0% |
| 2020 | 8.52 Million CAD | 30.28% |
| 2019 | -6.58 Million CAD | 111.99% |
| 2018 | 3.08 Million CAD | -77.64% |
| 2017 | 12.53 Million CAD | 15.25% |
| 2016 | 11.96 Million CAD | -14.67% |
| 2015 | 13.54 Million CAD | -43.43% |
| 2014 | 24.79 Million CAD | 60.41% |
| 2013 | 24.09 Million CAD | -47.43% |
| 2012 | 29.4 Million CAD | -57.22% |
| 2011 | 10.03 Million CAD | 826.69% |
| 2010 | 7.41 Million CAD | 121.97% |
| 2009 | 3.34 Million CAD | 80.13% |
| 2008 | 1.85 Million CAD | 36.45% |
| 2007 | 1.35 Million CAD | 146.12% |
| 2006 | 552.29 Thousand CAD | 320.24% |
| 2005 | -250.77 Thousand CAD | -134.55% |
| 2004 | 725.77 Thousand CAD | -43.32% |
| 2003 | 1.28 Million CAD | 2240.88% |
| 2002 | 345 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 7.14 Million CAD | -13.86% |
| 2024 Q1 | 6.96 Million CAD | -4.82% |
| 2023 Q3 | 7.25 Million CAD | 0.17% |
| 2023 Q1 | 6.27 Million CAD | 8.26% |
| 2023 Q4 | 7.05 Million CAD | -2.72% |
| 2023 FY | - CAD | -2.77% |
| 2023 Q2 | 7.24 Million CAD | 15.36% |
| 2022 Q2 | 7.89 Million CAD | 7.97% |
| 2022 Q3 | 6.91 Million CAD | -12.43% |
| 2022 Q4 | 5.79 Million CAD | -16.14% |
| 2022 FY | - CAD | 39.14% |
| 2022 Q1 | 7.31 Million CAD | 30.69% |
| 2021 Q4 | 5.59 Million CAD | 27.01% |
| 2021 Q3 | 4.4 Million CAD | 23.22% |
| 2021 Q2 | 3.57 Million CAD | 9.8% |
| 2021 Q1 | 3.25 Million CAD | 6.06% |
| 2021 FY | - CAD | 136.0% |
| 2020 Q2 | 915 Thousand CAD | -39.16% |
| 2020 Q1 | 1.5 Million CAD | 20.32% |
| 2020 FY | - CAD | 30.28% |
| 2020 Q3 | 3.1 Million CAD | 239.13% |
| 2020 Q4 | 3.07 Million CAD | -1.06% |
| 2019 Q2 | 1.73 Million CAD | 25.13% |
| 2019 Q1 | 1.38 Million CAD | 134.92% |
| 2019 FY | - CAD | 111.99% |
| 2019 Q4 | 1.25 Million CAD | -43.67% |
| 2019 Q3 | 2.21 Million CAD | 27.68% |
| 2018 Q2 | 2.83 Million CAD | -7.93% |
| 2018 Q4 | -3.97 Million CAD | -377.79% |
| 2018 FY | - CAD | -77.64% |
| 2018 Q1 | 3.07 Million CAD | -12.78% |
| 2018 Q3 | 1.43 Million CAD | -49.47% |
| 2017 Q1 | 2.88 Million CAD | -34.47% |
| 2017 FY | - CAD | 15.25% |
| 2017 Q4 | 3.52 Million CAD | -3.87% |
| 2017 Q3 | 3.67 Million CAD | -0.86% |
| 2017 Q2 | 3.7 Million CAD | 28.18% |
| 2016 Q1 | -185 Thousand CAD | 96.57% |
| 2016 Q2 | 3.66 Million CAD | 2079.46% |
| 2016 FY | - CAD | -14.67% |
| 2016 Q3 | 4.08 Million CAD | 11.5% |
| 2016 Q4 | 4.4 Million CAD | 7.98% |
| 2015 FY | - CAD | -43.43% |
| 2015 Q1 | 5.42 Million CAD | 2.36% |
| 2015 Q4 | -5.39 Million CAD | -184.4% |
| 2015 Q3 | 6.39 Million CAD | -15.9% |
| 2015 Q2 | 7.59 Million CAD | 40.0% |
| 2014 Q3 | 5.12 Million CAD | -32.72% |
| 2014 FY | - CAD | 60.41% |
| 2014 Q1 | 4.92 Million CAD | 405.39% |
| 2014 Q4 | 5.3 Million CAD | 3.47% |
| 2014 Q2 | 7.61 Million CAD | 54.61% |
| 2013 FY | - CAD | -47.43% |
| 2013 Q3 | 7.97 Million CAD | 137.51% |
| 2013 Q2 | 3.35 Million CAD | -41.39% |
| 2013 Q1 | 5.73 Million CAD | 258.75% |
| 2013 Q4 | -1.61 Million CAD | -120.22% |
| 2012 Q4 | -3.61 Million CAD | -140.86% |
| 2012 Q2 | 11.94 Million CAD | 12.9% |
| 2012 Q1 | 10.57 Million CAD | 119.59% |
| 2012 Q3 | 8.83 Million CAD | -26.0% |
| 2012 FY | - CAD | -57.22% |
| 2011 Q4 | -53.99 Million CAD | -190.7% |
| 2011 Q2 | 2.65 Million CAD | 147.3% |
| 2011 Q3 | 59.53 Million CAD | 2139.95% |
| 2011 Q1 | -5.62 Million CAD | -511.42% |
| 2011 FY | - CAD | 826.69% |
| 2010 Q1 | 1.81 Million CAD | 613.39% |
| 2010 FY | - CAD | 121.97% |
| 2010 Q2 | 2.31 Million CAD | 27.81% |
| 2010 Q4 | 1.36 Million CAD | -33.95% |
| 2010 Q3 | 2.06 Million CAD | -10.71% |
| 2009 Q3 | 1.64 Million CAD | 88.32% |
| 2009 Q1 | 587.29 Thousand CAD | -11.71% |
| 2009 Q2 | 870.84 Thousand CAD | 48.28% |
| 2009 FY | - CAD | 80.13% |
| 2009 Q4 | 254 Thousand CAD | -84.51% |
| 2008 Q3 | 348.43 Thousand CAD | -25.9% |
| 2008 Q4 | 665.16 Thousand CAD | 90.9% |
| 2008 FY | - CAD | 36.45% |
| 2008 Q1 | 370.99 Thousand CAD | 56.82% |
| 2008 Q2 | 470.19 Thousand CAD | 26.74% |
| 2007 Q3 | 239.26 Thousand CAD | -51.45% |
| 2007 Q2 | 492.87 Thousand CAD | 5.08% |
| 2007 Q1 | 469.05 Thousand CAD | 307.05% |
| 2007 FY | - CAD | 146.12% |
| 2007 Q4 | 236.56 Thousand CAD | -1.13% |
| 2006 Q1 | 304.2 Thousand CAD | 852.51% |
| 2006 FY | - CAD | 320.24% |
| 2006 Q2 | 329.81 Thousand CAD | 8.42% |
| 2006 Q4 | -226.54 Thousand CAD | -256.43% |
| 2006 Q3 | 144.81 Thousand CAD | -56.09% |
| 2005 Q3 | 104.39 Thousand CAD | 133.4% |
| 2005 Q1 | -74.5 Thousand CAD | -263.81% |
| 2005 FY | - CAD | -134.55% |
| 2005 Q2 | -312.6 Thousand CAD | -319.56% |
| 2005 Q4 | 31.93 Thousand CAD | -69.41% |
| 2004 Q2 | 328.43 Thousand CAD | 0.89% |
| 2004 FY | - CAD | -43.32% |
| 2004 Q4 | 45.48 Thousand CAD | 70.42% |
| 2004 Q3 | 26.69 Thousand CAD | -91.87% |
| 2004 Q1 | 325.52 Thousand CAD | -44.06% |
| 2003 Q2 | 264.21 Thousand CAD | 687.33% |
| 2003 Q1 | 219.65 Thousand CAD | -218.08% |
| 2003 FY | - CAD | 2240.88% |
| 2003 Q4 | 581.94 Thousand CAD | 241.85% |
| 2003 Q3 | 170.23 Thousand CAD | -35.57% |
| 2002 Q4 | -14.14 Thousand CAD | 59.01% |
| 2002 Q3 | 138.99 Thousand CAD | -208.89% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q2 | 229.74 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 324.437% |
| Arem Pacific Corporation | 36.71 Thousand USD | -67041.495% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 21932.24% |
| BioCorRx Inc. | -2.68 Million USD | 1018.469% |
| Bionik Laboratories Corp. | -4.77 Million USD | 616.174% |
| Banyan Corp. | 583.94 Thousand USD | -4121.481% |
| Clearday, Inc. | -7.53 Million USD | 427.093% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -191393.824% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 2365.136% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 1215.536% |
| Selectis Health, Inc. | -7.29 Million USD | 437.953% |
| Ethema Health Corporation | 2.07 Million USD | -1089.621% |
| HealthLynked Corp. | -2.75 Million USD | 996.301% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 1028.689% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -85357.256% |
| Comjoyful International Company | 167.89 Thousand USD | -14582.391% |
| Medical Facilities Corporation | 77.94 Million USD | 68.374% |
| MedSmart Group Inc. | 47.8 Thousand USD | -51461.421% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 4054.727% |
| Nova Leap Health Corp. | 994.46 Thousand USD | -2378.82% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 12319.799% |
| PAO Group, Inc. | 292.96 Thousand USD | -8314.373% |
| Primemd Inc. | 3.42 Million USD | -619.329% |
| Raffles Medical Group Ltd | 100.7 Million USD | 75.52% |
| Ryman Healthcare Limited | -54.51 Million USD | 145.217% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 582452.941% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 951.724% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 4537.568% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 50408.163% |
| Veltex Corporation | -938.45 Thousand USD | 2726.759% |
| World Financial Holding Group | -28.43 Thousand USD | 86807.703% |
| Xcelerate Inc. | -2.53 Million USD | 1071.145% |